Covered recipient · General Payments record
MILES C LAYTON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$6,088.81
- Reported across 313 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $652.99 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $264.46 | 15 |
| Corium, Inc. | $58.57 | 3 |
| PFIZER INC. | $45.79 | 3 |
| Novo Nordisk AS | $36.60 | 2 |
| Supernus Pharmaceuticals, Inc. | $31.77 | 2 |
| Axsome Therapeutics, Inc. | $26.23 | 1 |
| Xeris Pharmaceuticals, Inc. | $24.97 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $23.71 | 1 |
| DEXCOM, INC. | $23.12 | 1 |
| Organon LLC | $22.30 | 1 |
| Edwards Lifesciences Corporation | $22.13 | 1 |
| Lilly USA, LLC | $19.59 | 1 |
| Tris Pharma Inc | $19.40 | 1 |
| Cranial Technologies, Inc | $17.36 | 1 |
| GlaxoSmithKline, LLC. | $16.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.72 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145226 | CMS |
| ABBVIE INC. | $25.41 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145228 | CMS |
| ABBVIE INC. | $23.13 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145230 | CMS |
| ABBVIE INC. | $20.01 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145232 | CMS |
| ABBVIE INC. | $20.91 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145234 | CMS |
| ABBVIE INC. | $13.54 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145236 | CMS |
| ABBVIE INC. | $26.37 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145238 | CMS |
| ABBVIE INC. | $32.92 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145240 | CMS |
| ABBVIE INC. | $22.93 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145242 | CMS |
| ABBVIE INC. | $7.54 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145244 | CMS |
| ABBVIE INC. | $4.00 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145246 | CMS |
| ABBVIE INC. | $25.24 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145248 | CMS |
| ABBVIE INC. | $6.62 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145250 | CMS |
| ABBVIE INC. | $11.81 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145252 | CMS |
| ABBVIE INC. | $8.31 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104145254 | CMS |
| Axsome Therapeutics, Inc. | $26.23 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148306456 | CMS |
| Corium, LLC | $20.76 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100179912 | CMS |
| Corium, LLC | $19.29 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100175656 | CMS |
| Corium, LLC | $18.52 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108583878 | CMS |
| Cranial Technologies, Inc | $17.36 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082234562 | CMS |
| Dexcom, Inc. | $23.12 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153323334 | CMS |
| Edwards Lifesciences Corporation | $22.13 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138876679 | CMS |
| GlaxoSmithKline, LLC. | $16.99 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116245127 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $23.71 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146269512 | CMS |
| Lilly USA, LLC | $19.59 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135256341 | CMS |
| Novo Nordisk Inc | $18.05 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096636305 | CMS |
| Novo Nordisk Inc | $18.55 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621350 | CMS |
| Organon Llc | $22.30 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136234543 | CMS |
| PFIZER INC. | $16.90 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130987573 | CMS |
| PFIZER INC. | $14.45 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131275547 | CMS |
| PFIZER INC. | $14.44 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624419 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.37 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147856287 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.40 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147789534 | CMS |
| Tris Pharma Inc | $19.40 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147223236 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.97 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144606358 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.